BOOST

Teams from across BC join the BOOST QI Network Annual Congress virtually

The Best-practices in Oral Opioid AgoniSt Therapy (BOOST) Annual Congress was held last month amidst the dual public health emergencies of the COVID-19 pandemic and the opioid overdose crisis. Presenters at the congress shared how their teams are adapting their practices for the pandemic, how healthcare teams can better integrate the voices of families of those with opioid use disorder (OUD), and also shared ideas on how to support and improve retention for clients on opioid agonist therapy (OAT).

Teams from across BC join the BOOST QI Network Annual Congress virtually Read More »

New BC-CfE research seeks to improve COVID-19 nasal swab collection procedures

New research that will help improve sample quality and patient experience in COVID-19 testing was recently published by BC-CfE research assistants Natalie Kinloch and Aniqa Shahid. Kinloch and Shahid are also PhD students in the Faculty of Health Sciences at Simon Fraser University under the supervision of SFU Professor and BC-CfE laboratory director Dr. Zabrina

New BC-CfE research seeks to improve COVID-19 nasal swab collection procedures Read More »

BOOST and Coast Mental Health Collaboration Improves Lives of Those Living With OUD

More than 1,300 people have died from illicit drug poisoning in BC so far this year. Some months saw a death toll greater than double the same month the previous year, and June alone had 183 people die of an overdose. This was the highest monthly overdose related death toll in BC’s history.

BOOST and Coast Mental Health Collaboration Improves Lives of Those Living With OUD Read More »

Young adult pilot OAT clinic indicates harm reduction services saves lives

The number of deaths caused by drug poisoning far exceeds the deaths caused by the COVID-19 pandemic in British Columbia. The BC Coroners Services report states that 1,202 people have died this year from illicit drugs. Many of these fatalities occurred in a private residence when people with an opioid use disorder (OUD) were using

Young adult pilot OAT clinic indicates harm reduction services saves lives Read More »

BC-CfE launches BOOST Quality Improvement Network building on previous BOOST Collaboratives

With BC in the midst of two public health emergencies, one for COVID-19 and one for drug overdose deaths, the BC Centre for Excellence in HIV/AIDS (BC-CfE) has just launched a new Quality Improvement Network for its BOOST Collaborative (Best-Practices in Oral Opioid agoniSt Therapy). Led by Dr. Rolando Barrios, the BC-CfE’s Senior Medical Director,

BC-CfE launches BOOST Quality Improvement Network building on previous BOOST Collaboratives Read More »

Dr Cole Stanley: helping patients with Opioid Use Disorder

When opioid overdoses and deaths reached stunning proportions in 2016 and 2017, and a public health crisis was declared, Dr Cole Stanley recognized that he and his colleagues might be able to better serve their patients with opioid use disorder (OUD). Having recently completed quality improvement training by the Specialist Services Committee’s Physician Quality Improvement

Dr Cole Stanley: helping patients with Opioid Use Disorder Read More »

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)